- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07297745
일차성 알도스테론증의 치유 가능한 치료를 위한 알도스테론-하이브리드 스테로이드 시험
원발성 알도스테론증의 치유 가능한 치료를 안내하는 알도스테론-하이브리드 스테로이드 시험
The goal of this project is to improve the diagnostic pathway for patients with primary aldosteronism, by validating non-invasive biomarkers coupled with routine computed tomography imaging. The aim is to reduce reliance on invasive procedures, shorten diagnostic timelines, and enhance accessibility to definitive diagnosis and treatment globally.
연구 개요
상세 설명
Primary Aldosteronism is a common but under-diagnosed condition, despite being a curable cause of secondary hypertension with significant long-term health consequences if left untreated. Once the diagnosis of primary aldosteronism is confirmed, subtype tests are required to demonstrate unilateral primary aldosteronism before curative surgery. Most patients need to undergo adrenal vein sampling, an invasive procedure performed under radiological guidance. However, this procedure is technically-challenging, with failure to cannulate both adrenal veins frequently leading to inconclusive results. Many patients worldwide may be offered surgery based on computed tomography imaging alone because of a lack of adrenal vein sampling expertise or a failed adrenal vein sampling result.
High hybrid hormones indicate a functional KCNJ5-mutant aldosterone-producing adenoma and, when coupled with computed tomography imaging, may provide a non-invasive alternative to adrenal vein sampling for identifying unilateral primary aldosteronism.
Ultimately, this trial aims to reduce the number of patients that will require an invasive adrenal vein sampling in future clinical diagnostics. This will improve access, and allow more patients to receive timely and curative treatment.
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Troy H Puar, FRCP, PhD
- 전화번호: 67888833
- 이메일: troy_puar@cgh.com.sg
연구 장소
-
-
-
Singapore, 싱가포르
- 모병
- National University Hospital
-
연락하다:
- Ada Teo
- 전화번호: +65 6908 2222
- 이메일: ada_ed_teo@nuhs.edu.sg
-
수석 연구원:
- Ada Teo
-
Singapore, 싱가포르
- 모병
- Singapore General Hospital
-
연락하다:
- Swee Du Soon
- 전화번호: +65 6222 3322
- 이메일: swee.du.soon@singhealth.com.sg
-
수석 연구원:
- Swee Du Soon
-
Singapore, 싱가포르
- 아직 모집하지 않음
- Khoo Teck Puat Hospital
-
연락하다:
- Niyati Jauhar
- 전화번호: +65 6555 8000
- 이메일: jauhar.niyati@nhghealth.com.sg
-
수석 연구원:
- Niyati Jauhar
-
Singapore, 싱가포르
- 아직 모집하지 않음
- Tan Tock Seng Hospital
-
연락하다:
- Lai Tian Rui Ray
- 전화번호: +65 6357 3078
- 이메일: ray.tr.lai@nhghealth.com.sg
-
수석 연구원:
- Lai Tian Rui Ray
-
Singapore, 싱가포르
- 모병
- Sengkang General Hospital
-
연락하다:
- Matthew Chuah
- 전화번호: +65 6930 5000
- 이메일: matthew.chuah@singhealth.com.sg
-
수석 연구원:
- Matthew Chuah Bingfeng
-
-
Singapore
-
Singapore, Singapore, 싱가포르, 529889
- 모병
- Changi General Hospital
-
연락하다:
- Troy H Puar, FRCP, PhD
- 전화번호: +65 68503967
- 이메일: troy_puar@cgh.com.sg
-
수석 연구원:
- Troy H Puar, FRCP, PhD
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Confirmed diagnosis of primary aldosteronism according to the Endocrine Society guideline 2025.
- Willing to undergo subtype testing with adrenal vein sampling and/or molecular imaging (Positron Emission Tomography/Computed Tomography, PET/CT).
- Keen for surgical treatment if shown to have unilateral primary aldosteronism.
Exclusion Criteria:
- Inability to provide written informed consent.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 특수 증상
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Hybrid hormones
Previous studies have shown that hybrid hormones are elevated in patients with unilateral primary aldosteronism who have large, visible adenomas in their adrenal glands. These tumors harbour a somatic KCNJ5 mutation and are also most likely to be cured of hypertension after surgery. Hence, the investigators hypothesize that high hybrid hormones levels, in the presence of an adenoma on a computed tomography imaging would identify study participants who can proceed to surgery. |
Participants will have a baseline blood sample taken so the investigators can measure the adrenal steroid biomarkers 18-oxocortisol, 18-hydroxylcortisol and other steroids. The collected plasma or serum will then be analyzed in the laboratory using validated methods, such as liquid chromatography-tandem mass spectrometry (LC-MS/MS), to determine the levels of these biomarkers. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Proportion of participants with complete biochemical success after unilateral adrenalectomy for unilateral primary aldosteronism using Primary Aldosteronism Surgical Outcome (PASO) measured at least six months post-adrenalectomy.
기간: 6 months
|
Proportion of participants with correction of hypokalaemia and normalisation of aldosterone-renin-ratio following unilateral adrenalectomy, as per PASO criteria. |
6 months
|
|
Proportion of participants with KCNJ5-mutant aldosterone producing adenoma/nodule
기간: 6 months
|
Proportion of participants with histopathology and genetic confirmation of KCNJ5-mutant aldosterone producing adenoma/nodule in resected adrenals. |
6 months
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Proportion of participants with complete clinical success after unilateral adrenalectomy for unilateral primary aldosteronism using Primary Aldosteronism Surgical Outcome (PASO) measured at least six months post-adrenalectomy.
기간: 6 months
|
Proportion of participants with reduction in blood pressure and reduction anti-hypertensive medication following unilateral adrenalectomy, as per PASO criteria. |
6 months
|
|
Cost-effectiveness of using hybrid hormones coupled with computed tomography imaging versus other subtyping tests including adrenal vein sampling and/or molecular imaging in diagnosing participants with unilateral primary aldosteronism
기간: 6 months
|
Cost-effectiveness of the diagnostic course will be calculated by using calculated costs per quality-adjusted life years (QALYs) |
6 months
|
|
Diagnostic criteria using hybrid hormones/ steroid profiling coupled with computed tomography imaging
기간: 6 months
|
The criteria of hybrid hormones/ steroid profiling coupled with computed tomography imaging which offer the best sensitivity and specificity for lateralization of aldosterone-producing adenoma. |
6 months
|
공동 작업자 및 조사자
협력자
수사관
- 수석 연구원: Troy Puar, FRCP, PhD, Changi General Hospital
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .